Literature DB >> 17306879

Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study.

Rohit Varma1, Ginger L Macias, Mina Torres, Ronald Klein, Fernando Y Peña, Stanley P Azen.   

Abstract

OBJECTIVE: To identify biologic risk factors associated with having diabetic retinopathy (DR) in Latinos with type 2 diabetes mellitus (T2DM).
DESIGN: Population-based cross-sectional study. PARTICIPANTS: Six thousand three hundred fifty-seven Latinos ages > or =40 years from 6 census tracts in Los Angeles, California.
METHODS: An in-home interview was administered to all participants in the Los Angeles Latino Eye Study (LALES). All participants diagnosed with T2DM underwent a complete ophthalmologic examination including stereoscopic fundus photography (7 standard Early Treatment Diabetic Retinopathy Study fields). Photographs were graded in a masked manner using a modified Airlie House grading system to assess presence and severity of DR. Univariate and stepwise logistic regression analyses were used to identify independent risk factors. MAIN OUTCOME MEASURES: Biologic risk factors associated with any DR and proliferative DR (PDR).
RESULTS: Of the 7789 eligible individuals in LALES, 6357 (82%) had a clinical examination. One thousand two hundred sixty-three participants had definite diabetes and 1187 Latinos had T2DM. Of those with T2DM, 46% (544) had DR. Stepwise logistic regression analyses revealed that compared with females, males had a 50% higher risk of having any DR (OR = 1.50; P = 0.006). Factors independently associated with a greater risk of having any DR were longer duration of known diabetes (per year, OR = 1.08, P<0.0001), higher glycosylated hemoglobin levels (per 1%, OR = 1.22, P<0.0001); higher systolic blood pressure (per 20 mmHg, OR = 1.26, P = 0.002); and insulin treatment (OR = 1.60, P = 0.01). Factors independently associated with PDR included longer duration of known diabetes (per year, OR = 1.06, P<0.0001); being on insulin treatment (OR = 3.2, P<0.0001); and a higher systolic blood pressure (per 20 mmHg, OR = 1.44, P = 0.01). The relationship of these variables to the risk of having DR or PDR is not a constant linear function in all cases and varies depending on the variable.
CONCLUSIONS: Our study showed that the high risk of DR in adult Latinos is independently associated with both nonmodifiable and modifiable risk factors. These findings suggest that controlling hyperglycemia and hypertension in this ethnic group may reduce the high risk of having DR associated with T2DM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306879     DOI: 10.1016/j.ophtha.2006.10.023

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  37 in total

Review 1.  Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure.

Authors:  Jost B Jonas; Liang Xu; Jie Xu; Wen Bin Wei; Ya Xing Wang
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

2.  Prevalence and risk factors of diabetic retinopathy in Chongqing pre-diabetes patients.

Authors:  X Chen; Y Zhao; Z Zhou; X Zhang; Q Li; L Bai; M Zhang
Journal:  Eye (Lond)       Date:  2012-03-23       Impact factor: 3.775

3.  Prevalence of and risk factors for diabetic macular edema in the United States.

Authors:  Rohit Varma; Neil M Bressler; Quan V Doan; Michelle Gleeson; Mark Danese; Julie K Bower; Elizabeth Selvin; Chantal Dolan; Jennifer Fine; Shoshana Colman; Adam Turpcu
Journal:  JAMA Ophthalmol       Date:  2014-11       Impact factor: 7.389

4.  Native American ancestry is associated with severe diabetic retinopathy in Latinos.

Authors:  Xiaoyi Gao; W James Gauderman; Paul Marjoram; Mina Torres; Yii-Der I Chen; Kent D Taylor; Jerome I Rotter; Rohit Varma
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-21       Impact factor: 4.799

Review 5.  Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review.

Authors:  Bengi Ece Kurtul; Pinar Altiaylik Ozer
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

6.  Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy.

Authors:  Wendy W Harrison; Marcus A Bearse; Marilyn E Schneck; Brian E Wolff; Nicholas P Jewell; Shirin Barez; Andrew B Mick; Bernard J Dolan; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

7.  Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study.

Authors:  Rohit Varma; Farzana Choudhury; Ronald Klein; Jessica Chung; Mina Torres; Stanley P Azen
Journal:  Am J Ophthalmol       Date:  2010-02-10       Impact factor: 5.258

8.  Heritability of the severity of diabetic retinopathy: the FIND-Eye study.

Authors:  Nedal H Arar; Barry I Freedman; Sharon G Adler; Sudha K Iyengar; Emily Y Chew; Mathew D Davis; Scott G Satko; Donald W Bowden; Ravi Duggirala; Robert C Elston; Xiuxing Guo; Robert L Hanson; Robert P Igo; Eli Ipp; Paul L Kimmel; William C Knowler; Julio Molineros; Robert G Nelson; Madeleine V Pahl; Shannon R E Quade; Rebekah S Rasooly; Jerome I Rotter; Mohammed F Saad; Marina Scavini; Jeffrey R Schelling; John R Sedor; Vallabh O Shah; Philip G Zager; Hanna E Abboud
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09       Impact factor: 4.799

9.  Measurement of retinal function with flash-electroretinography in Chinese patients with hyperlipidemia.

Authors:  Bei Zhang; Qinghua Qiu; Lili Yin; Yuan Yao; Chuan Wang; Xingwei Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-17       Impact factor: 3.117

10.  Prevalence of diabetic retinopathy in Tehran province: a population-based study.

Authors:  Mohammad Ali Javadi; Marzieh Katibeh; Nasrin Rafati; Mohammad Hossein Dehghan; Farid Zayeri; Mehdi Yaseri; Mojtaba Sehat; Hamid Ahmadieh
Journal:  BMC Ophthalmol       Date:  2009-10-16       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.